查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1944901

ECMO耗材市场：按产品、支援模式、应用和最终用户划分，全球预测，2026-2032年

ECMO Consumables Market by Product, Mode Of Support, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

ECMO耗材市场预计到2025年将达到5.5484亿美元，到2026年将成长到5.9441亿美元，到2032年将达到9.1037亿美元，年复合成长率为7.33%。

关键市场统计数据
基准年 2025 5.5484亿美元
预计年份：2026年 5.9441亿美元
预测年份 2032 9.1037亿美元
复合年增长率 (%) 7.33%

ECMO耗材权威架构明确了临床依赖、关键供应链问题以及策略性相关人员的采购决策驱动因素。

体外膜氧合（ECMO）耗材处于急性临床照护和复杂的医疗设备供应链之间的关键环节。这些耗材是生命支持迴路的必需品，其可用性、设计和监管状态直接影响心臟和呼吸支持的临床结果。临床医生、医院采购团队和医疗设备负责人越来越认识到，耗材并非简单的可互换商品，而是影响治疗效果、病人安全和总医疗成本的关键组成部分。

材料技术、互通性和供应链模式的进步如何重塑体外膜氧合（ECMO）耗材的临床应用和采购重点

体外膜氧合（ECMO）耗材领域正经历变革性的转变，这主要得益于技术改进、临床通讯协定的不断改进以及供应链的调整。聚合物化学和表面处理技术的进步降低了血栓形成倾向，提高了预充效率，使临床医生能够延长安全运作并简化迴路组装。同时，紧凑型感测器套件和标准化连接器的整合提高了互通性，减轻了灌注团队的认知和操作负担，并实现了在紧急情况下的快速部署。

近期美国关税调整对体外膜氧合（ECMO）耗材产业的筹资策略、供应韧性和製造商在地化选择的影响

关税和贸易政策环境会对体外膜氧合（ECMO）耗材的筹资策略产生重大影响，尤其是那些製造地集中的组件。美国近期调整关税后，进口组件的成本核算更加严格，促使医疗机构和经销商重新评估其供应商组合，并在条件允许的情况下加快本地化进程。这些政策讯号也活性化製造商和监管机构就替代供应商的资格认证以及确保双重采购途径展开对话。

多维細項分析揭示了产品类别、临床应用、支援模式和最终用户类型如何影响耗材选择和供应策略。

细分市场层面的趋势揭示了不同产品类型、病患小组、支持方式和最终用户类型所面临的独特驱动因素和限制因素，这些因素塑造了需求特征和采购行为。产品细分涵盖插管、热交换器、氧合器、泵头和管路组件，其中泵头类别又细分为离心式帮浦头和滚压泵头。每类产品都需要不同的检验、库存策略和临床培训。成人、新生儿和儿童等不同应用群体对产品的尺寸、流速和血液接触材料提出了独特的要求，从而影响了产品型号的复杂性和灭菌通讯协定。

区域在製造、监管协调和分销方面的策略重点将影响全球医疗保健生态系统的准入和临床应用。

区域趋势显着影响体外膜氧合（ECMO）耗材的製造地、监管路径和分销模式，从而为销售团队制定了明确的策略重点。在美洲，集中式医院系统和区域采购组织倾向于签订长期合同，并强调成人护理的扩充性，同时透过有针对性的分销网络为新生儿和儿童专科中心提供支援。在欧洲、中东和非洲地区（EMEA），由于法规结构和报销环境的差异，製造商需要根据当地情况定制监管文件和註册策略，尤其要关注当地的灭菌方法和标籤规范。

关键的竞争和合作伙伴趋势正在透过临床整合、售后服务和强大的分销模式来塑造差异化优势。

ECMO耗材供应商之间的竞争日益受到创新组合、服务模式和策略伙伴关係关係的影响，而不再仅限于产品价格。主要企业正致力于材料改进、连接器标准化和整合监控功能，以提升临床易用性并减少操作失误。同时，各企业也正在投资现场培训专案、虚拟模拟模组和临床顾问委员会，以推动产品应用并建立值得信赖的使用者群体。

製造商和医疗保健系统可采取的切实可行的策略重点，以提高体外膜氧合（ECMO）耗材市场的韧性、临床应用率和收入永续性

产业领导者应采取一套平衡的战术性和策略措施，以确保其在体外膜氧合（ECMO）耗材领域的长期地位。首先，实施双源生产策略，并在监管和经济条件有利于在地化的地区投资本地生产。这有助于降低关税和物流衝击带来的风险，并缩短补货週期。其次，在产品设计中优先考虑人因工程和互通性，确保设备能够无缝整合到不同的灌注流程中。这有助于减轻培训负担，并减少操作流程的差异。

结合专家访谈、设备检验和供应链分析的严谨混合调查方法，确保了可靠且可操作的策略洞察。

本研究采用混合方法，结合了对关键相关人员的访谈、针对特定设备的分析以及对二级资讯来源的检验，以得出可靠的循证结论。主要输入包括对循环系统、重症监护专家、医院采购人员和监管专家的结构化访谈，以了解当地的优先事项和营运限制。设备层面的评估包括材料评估、连接器相容性审查和可用性测试，以比较不同代表性耗材类别之间的性能特征。

本文综合分析了各项策略需求，阐述了临床表现、供应韧性和商业化策略如何决定体外膜氧合（ECMO）耗材的领先地位。

总之，ECMO耗材是现代重症监护流程的核心，需要製造商、经销商和医疗系统协同应对，以满足不断变化的临床、监管和物流需求。技术进步和互通性标准的提升正在提高临床应用价值，而关税和贸易趋势正在重塑筹资策略和区域生产重点。针对不同产品类型、目标患者群体、支持模式和最终用户类别的具体考量，凸显了有针对性的证据生成和差异化市场推广模式的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 ECMO耗材市场：依产品分类

  • 套管
  • 热交换器
  • 氧合设备
  • 泵浦头
    • 离心式帮浦泵头
    • 滚筒泵头
  • 管集

第九章 以支援方式分類的体外膜氧合（ECMO）耗材市场

  • 静脉-动脉体外膜氧合（ECMO）
  • 静脉-静脉体外膜氧合（VV-ECMO）

第十章 ECMO耗材市场：依应用领域划分

  • 成人版
  • 新生
  • 儿童

第十一章 ECMO耗材市场（依最终用户划分）

  • 医院
    • 公立医院
      • 大学医院
      • 社区医院
    • 私立医院
  • 专科诊所

第十二章 ECMO耗材市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 ECMO耗材市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国体外膜氧合（ECMO）耗材市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 美国体外膜氧合（ECMO）耗材市场

第十六章 中国体外膜氧合（ECMO）耗材市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Braile Biomedica
  • Chalice Medical Ltd.
  • Changzheng Medical Co., Ltd.
  • Chinabridge（Shenzhen）Medical Technology Co., Ltd.
  • CytoSorbents Corporation
  • Edwards Lifesciences Corporation
  • Eurosets Srl
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Hemovent GmbH
  • LivaNova PLC
  • MAQUET GmbH
  • MC3 Cardiopulmonary
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Neotech Products, Inc.
  • Nihon Kohden Corporation
  • Nipro Corporation
  • Spectrum Medical（UK）Limited
  • Terumo Corporation
  • ZOLL Medical Corporation
Product Code: MRR-F847BD9C7499

The ECMO Consumables Market was valued at USD 554.84 million in 2025 and is projected to grow to USD 594.41 million in 2026, with a CAGR of 7.33%, reaching USD 910.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 554.84 million
Estimated Year [2026] USD 594.41 million
Forecast Year [2032] USD 910.37 million
CAGR (%) 7.33%

An authoritative framing of ECMO consumables that clarifies clinical dependencies, supply chain imperatives, and procurement decision drivers for strategic stakeholders

Extracorporeal membrane oxygenation (ECMO) consumables occupy a critical junction between acute clinical care and intricate medical-device supply chains. These consumables are integral to life-sustaining circuits, and their availability, design, and regulatory status directly influence clinical outcomes in cardiac and respiratory support. Clinicians, hospital procurement teams, and medical device strategists increasingly view consumables not as interchangeable commodities but as components that shape therapy performance, patient safety, and total cost of care.

In recent years the ecosystem surrounding these supplies has matured, with manufacturers investing in materials science, compatibility validation, and sterile packaging innovations to reduce failure modes and improve shelf life. Meanwhile, health systems have elevated their sourcing strategies, emphasizing supplier qualification, traceability, and post-market surveillance. As a result, decision-makers must weigh technical compatibility, clinical evidence, and logistical reliability when specifying consumables for ECMO programs.

This report synthesizes clinical, regulatory, and commercial perspectives to help stakeholders understand how consumables function within broader care pathways. It aims to clarify the drivers of procurement decisions and the operational constraints that shape supply continuity, thereby equipping leaders with the context necessary to align product development, contracting, and clinical adoption strategies.

How advances in materials, interoperability, and supply chain models are reshaping clinical use and procurement priorities for ECMO consumables

The landscape for ECMO consumables is undergoing transformative shifts driven by technological refinement, clinical protocol evolution, and supply chain recalibration. Advances in polymer chemistry and surface treatments have reduced thrombogenicity and improved priming efficiency, enabling clinicians to extend safe run times and simplify circuit assembly. Concurrently, the integration of compact sensor suites and standardized connectors has improved interoperability, reducing the cognitive and procedural burden on perfusion teams and enabling faster deployment in emergency scenarios.

Clinical practice changes are also reshaping demand profiles. Expanded adoption of ECMO in community settings, greater use in nontraditional indications, and protocol-driven earlier intervention point to broader consumable requirements across adult and pediatric cohorts. At the same time, regulatory emphasis on human factors engineering and post-market traceability is prompting manufacturers to design consumables with clearer labeling, sterilization validation, and tamper-evident features.

Supply chain innovation has paralleled clinical and technological progress. Manufacturers and distributors are adopting just-in-time and vendor-managed inventory models, while advanced analytics are optimizing reorder points and minimizing stockouts. Taken together, these shifts are redefining value propositions: performance and reliability now compete alongside cost and availability as determinants of procurement choice, and industry participants must prioritize cross-functional alignment to capture emerging opportunities.

Implications of recent United States tariff adjustments on procurement strategies, supply resilience, and manufacturer localization choices in the ECMO consumables sector

The policy environment surrounding tariffs and trade measures can materially influence sourcing strategies for ECMO consumables, particularly for components with concentrated manufacturing footprints. Recent tariff adjustments in the United States have elevated the cost calculus for imported components, prompting health systems and distributors to reassess supplier portfolios and to accelerate localization efforts where feasible. These policy signals have also intensified dialogue between manufacturers and regulatory teams about qualifying alternate suppliers and securing dual-source pathways.

As a consequence, procurement teams are evaluating the trade-offs between domestic sourcing premiums and the operational risks of single-supplier dependency. Manufacturers face added pressure to demonstrate resilient supply chains, which often requires qualifying secondary manufacturing sites, increasing inventory buffers, or investing in regional production capabilities. At the same time, distributors and hospital networks are exploring longer-term contracting mechanisms and demand-aggregation strategies to dilute tariff impacts across larger purchasing volumes.

Importantly, tariff-driven cost pass-throughs can influence clinical adoption timelines for elective or non-urgent indications, but they also catalyze strategic responses that strengthen overall supply continuity. Stakeholders should anticipate ongoing policy flux and embed scenario planning into sourcing strategies to maintain clinical readiness while managing cost pressures and compliance requirements.

A multidimensional segmentation analysis that illuminates how product classes, clinical applications, support modes, and end-user types drive consumable selection and supply strategies

Segment-level dynamics reveal differentiated drivers and constraints across product categories, patient groups, modes of support, and end-user types that shape demand characteristics and procurement behavior. Product segmentation encompasses Cannula, Heat Exchanger, Oxygenator, Pump Head, and Tubing Set, with specific attention to the Pump Head category subdivided into Centrifugal Pump Head and Roller Pump Head; each product class demands distinct validation, inventory strategies, and clinical training considerations. Application segmentation across Adult, Neonatal, and Pediatric cohorts imposes unique size, flow, and blood-contact material requirements that influence SKU complexity and sterility protocols.

Mode of support segmentation differentiates Venoarterial ECMO from Venovenous ECMO, and each mode introduces particular component stressors and monitoring needs that inform selection criteria for oxygenators and pump heads. End-user segmentation separates Hospitals and Specialty Clinics, with Hospitals further classified as Government Hospitals and Private Hospitals, and Government Hospitals subdivided into Academic Medical Centers and Community Hospitals; these categories exhibit diverging procurement mandates, contracting cycles, and clinical capabilities, which in turn affect purchasing lead times and product adoption thresholds.

Understanding how these segment dimensions intersect is essential for manufacturers and distributors seeking to prioritize investments, align clinical evidence generation with target users, and design inventory strategies that respect both clinical performance requirements and operational economics.

Regional strategic priorities for manufacturing, regulatory alignment, and distribution that determine access pathways and clinical adoption across global healthcare ecosystems

Regional dynamics significantly influence manufacturing footprints, regulatory pathways, and distribution models for ECMO consumables, and they create distinct strategic priorities for commercial teams. In the Americas, centralized hospital systems and regional group purchasing organizations often negotiate long-term contracts and emphasize scalability for adult care, while also supporting neonatal and pediatric specialty centers through targeted distribution networks. Europe, Middle East & Africa features diverse regulatory frameworks and reimbursement environments that require manufacturers to tailor regulatory dossiers and local registration strategies, with particular attention to localized sterilization and labeling conventions.

Asia-Pacific exhibits a heterogeneous mix of advanced tertiary hospitals and rapidly expanding community care capabilities, which creates simultaneous demand for high-performance consumables and cost-effective variants; manufacturers often adopt tiered product strategies to serve both premium centers and high-volume regional hospitals. Logistics, customs processes, and cold-chain capabilities differ across these regions, so companies must build flexible distribution channels and localized after-sales support to maintain uptime and clinician confidence.

Taken together, regional considerations should guide product roadmaps, clinical evidence generation, and go-to-market models. Companies that adapt regulatory strategies and supply operations to regional nuances will more effectively manage time-to-market and post-market surveillance obligations while serving diverse clinical ecosystems.

Key competitive and partnership trends that shape differentiation through clinical integration, aftermarket services, and resilient distribution models

Competitive dynamics among suppliers of ECMO consumables increasingly hinge on innovation portfolios, service models, and strategic partnerships rather than on commodity pricing alone. Leading firms emphasize incremental material improvements, connector standardization, and integrated monitoring capabilities to differentiate on clinical usability and to reduce procedural errors. At the same time, companies are investing in in-service training programs, virtual simulation modules, and clinical advisory boards to accelerate adoption and to build high-confidence user communities.

Partnership activity is another salient trend: manufacturers collaborate with clinical centers to validate new designs and with logistics providers to develop resilient distribution networks that support critical-care uptime. Aftermarket services, including certified reprocessing programs where regulatory frameworks permit, and extended warranty or rapid-replacement agreements, are becoming important levers to lock in long-term relationships with high-volume hospital systems.

Strategic acquirers and investors are also watching for companies that combine robust clinical evidence with scalable manufacturing capabilities, as these attributes reduce adoption friction and ease hospital credentialing. For competitive planning, companies should prioritize capabilities that increase the total cost of switching and that deepen clinical integration, such as proprietary connector systems, validated clinical protocols, and comprehensive training infrastructures.

Actionable strategic priorities for manufacturers and health systems to enhance resilience, clinical adoption, and revenue sustainability in the ECMO consumables market

Industry leaders should pursue a balanced set of tactical and strategic initiatives to secure long-term positioning in the ECMO consumables space. First, invest in dual-source manufacturing strategies and localized production where regulatory and economic conditions support regionalization; this reduces exposure to tariff and logistics shocks and shortens replenishment cycles. Second, prioritize human factors and interoperability in product design so that devices integrate seamlessly into diverse perfusion workflows, reducing training burdens and procedural variation.

Third, develop comprehensive clinical validation plans that pair objective performance metrics with real-world use evidence; publish peer-reviewed outcomes to accelerate trust among clinicians and purchasing committees. Fourth, expand service offerings beyond product delivery by providing certified training, rapid-response replacement programs, and data-enabled inventory management to increase switching costs and improve uptime. Fifth, negotiate multi-year supply agreements with clear escalation and continuity clauses to stabilize demand and to enable capital investments in capacity.

Finally, maintain active policy engagement and scenario planning around trade measures and regulatory changes. By combining operational resilience, clinical partnerships, and service-oriented commercialization, industry leaders can convert uncertainty into competitive advantage and deliver measurable improvements in patient care pathways.

A rigorous mixed-methods research approach combining expert interviews, device validation, and supply-chain mapping to ensure reliable and actionable strategic insights

This research employed a mixed-methods approach that integrated primary stakeholder interviews, targeted device analysis, and secondary-source triangulation to produce robust, evidence-based insights. Primary inputs included structured interviews with perfusionists, critical-care physicians, hospital procurement leaders, and regulatory specialists to capture on-the-ground priorities and operational constraints. Device-level assessments incorporated materials evaluation, connector compatibility reviews, and usability testing to compare performance attributes across representative consumable categories.

Secondary research drew on peer-reviewed clinical literature, regulatory databases, and publicly available supplier documentation to validate technology trends and to contextualize policy impacts. Quantitative supply-chain mapping used shipment and customs data where permitted, combined with distributor network analysis to identify concentration risks and lead-time sensitivities. All inputs were cross-validated through a triangulation process to minimize bias and to ensure consistency between clinical practice and commercial realities.

The study also acknowledges limitations: proprietary contract terms and confidential supplier arrangements can obscure certain pricing and inventory behaviors, and rapid regulatory changes may affect time-sensitive compliance requirements. To mitigate these constraints, the methodology incorporated scenario analysis and sensitivity testing to highlight robust strategic options under varying market conditions.

Synthesis of strategic imperatives showing how clinical performance, supply resilience, and commercialization strategies determine leadership in ECMO consumables

In conclusion, ECMO consumables are central to contemporary critical care pathways and demand a coordinated response from manufacturers, distributors, and health systems to meet evolving clinical, regulatory, and logistical expectations. Technological improvements and interoperability standards are enhancing clinical usability, while tariff and trade dynamics are reshaping sourcing strategies and regional production priorities. Segment-specific considerations-spanning product types, application cohorts, modes of support, and end-user categories-underscore the importance of targeted evidence generation and differentiated go-to-market models.

Companies that invest in resilient supply chains, prioritize human factors in product design, and develop comprehensive service offerings will be better positioned to capture long-term value. Likewise, health systems that integrate scenario planning for trade policy shifts and that engage in collaborative supplier partnerships can strengthen clinical readiness and reduce operational risk. Ultimately, the intersection of clinical performance, supply reliability, and strategic commercialization will determine which organizations lead in delivering safe, effective, and readily available ECMO consumables.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. ECMO Consumables Market, by Product

  • 8.1. Cannula
  • 8.2. Heat Exchanger
  • 8.3. Oxygenator
  • 8.4. Pump Head
    • 8.4.1. Centrifugal Pump Head
    • 8.4.2. Roller Pump Head
  • 8.5. Tubing Set

9. ECMO Consumables Market, by Mode Of Support

  • 9.1. Venoarterial ECMO
  • 9.2. Venovenous ECMO

10. ECMO Consumables Market, by Application

  • 10.1. Adult
  • 10.2. Neonatal
  • 10.3. Pediatric

11. ECMO Consumables Market, by End User

  • 11.1. Hospitals
    • 11.1.1. Government Hospitals
      • 11.1.1.1. Academic Medical Centers
      • 11.1.1.2. Community Hospitals
    • 11.1.2. Private Hospitals
  • 11.2. Specialty Clinics

12. ECMO Consumables Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. ECMO Consumables Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. ECMO Consumables Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States ECMO Consumables Market

16. China ECMO Consumables Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abiomed, Inc.
  • 17.6. Asahi Kasei Medical Co., Ltd.
  • 17.7. Baxter International Inc.
  • 17.8. Becton Dickinson and Company
  • 17.9. Braile Biomedica
  • 17.10. Chalice Medical Ltd.
  • 17.11. Changzheng Medical Co., Ltd.
  • 17.12. Chinabridge (Shenzhen) Medical Technology Co., Ltd.
  • 17.13. CytoSorbents Corporation
  • 17.14. Edwards Lifesciences Corporation
  • 17.15. Eurosets S.r.l.
  • 17.16. Fresenius Medical Care AG & Co. KGaA
  • 17.17. Getinge AB
  • 17.18. Hemovent GmbH
  • 17.19. LivaNova PLC
  • 17.20. MAQUET GmbH
  • 17.21. MC3 Cardiopulmonary
  • 17.22. Medtronic plc
  • 17.23. MicroPort Scientific Corporation
  • 17.24. Neotech Products, Inc.
  • 17.25. Nihon Kohden Corporation
  • 17.26. Nipro Corporation
  • 17.27. Spectrum Medical (UK) Limited
  • 17.28. Terumo Corporation
  • 17.29. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ECMO CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ECMO CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CENTRIFUGAL PUMP HEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CENTRIFUGAL PUMP HEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CENTRIFUGAL PUMP HEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ROLLER PUMP HEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ROLLER PUMP HEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ROLLER PUMP HEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY TUBING SET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY TUBING SET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY TUBING SET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NATO ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)